Stephanie Lheureux

28PUBLICATIONS
278CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersPharmacogenomicsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Oct 27, 2026
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Living Guideline, Version 2026.1.0.

|Oct 20, 2026
Comparative analysis of ovarian cancer tumor-infiltrating T cells with those in melanoma and before and after PD-1 blockade.

|Aug 13, 2026
Immune Checkpoint Blockade Sensitivity Is Linked to Endogenous Retroelement Transcriptional Changes in Cancer.

|Jun 01, 2026
Antibody-drug conjugates in gynecologic cancers.

|Mar 26, 2026
Preclinical Combination Targeting VEGF and PI3K in a Rare, Aggressive Mixed Endometrial Carcinoma: An Applied Case Report.

Nikolina Radulovich, Pamela Soberanis Pina, Molly L Udaskin

|Jan 21, 2026
Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response Aberrations: Preclinical and Phase Ib Results.

Ezra Y Rosen, Timothy A Yap, Elisa Fontana

Pageof 5

Frequent Collaborators

7 joint publications

Amit Oza

4 joint publications

Trevor J Pugh

4 joint publications

Philippe L Bedard

3 joint publications

Neesha Dhani